These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 10451355)

  • 21. Plasma concentrations of non-esterified fatty acids in chronic renal failure in the United Arab Emirates.
    Gillett MP; Obineche EN; Khan ST; Abdulle AM
    Saudi Med J; 2004 Nov; 25(11):1611-6. PubMed ID: 15573187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute and long-term effects of low-density lipoprotein (LDL)-apheresis on oxidative damage to LDL and reducing capacity of erythrocytes in patients with severe familial hypercholesterolaemia.
    Stefanutti C; Di Giacomo S; Vivenzio A; Isacchi GC; Masella R; Caprari P; Varì R; Tarzia A; Mosiello A; Cantafora A
    Clin Sci (Lond); 2001 Feb; 100(2):191-8. PubMed ID: 11171288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced susceptibility of low-density lipoprotein to oxidation in wet type age-related macular degeneration in male patients.
    Javadzadeh A; Ghorbanihaghjo A; Rashtchizadeh N; Rafeey M; Rahimi-Ardabili B
    Saudi Med J; 2007 Feb; 28(2):221-4. PubMed ID: 17268700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients.
    Adragao T; Pires A; Lucas C; Birne R; Magalhaes L; Gonçalves M; Negrao AP
    Nephrol Dial Transplant; 2004 Jun; 19(6):1480-8. PubMed ID: 15034154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiopoietin 2 and cardiovascular disease in dialysis and kidney transplantation.
    David S; Kümpers P; Hellpap J; Horn R; Leitolf H; Haller H; Kielstein JT
    Am J Kidney Dis; 2009 May; 53(5):770-8. PubMed ID: 19268412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxidation of low density lipoprotein in hemodialysis patients: effect of dialysis and comparison with matched controls.
    Westhuyzen J; Saltissi D; Healy H
    Atherosclerosis; 1997 Mar; 129(2):199-205. PubMed ID: 9105562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of low-density lipoprotein apheresis in patients with peripheral arterial occlusive disease undergoing hemodialysis treatment.
    Morimoto S; Yano Y; Maki K; Sawada K; Iwasaka T
    Am J Nephrol; 2007; 27(6):643-8. PubMed ID: 17878713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Oxidative stress in end stage renal disease: evidence and association with cardiovascular events in Tunisian patients].
    Fellah H; Feki M; Souissi M; Ghorbel H; Ben Abdallah T; Massy Z; Hedhili A; Ben Maiz H; Lacour B; Kaabachi N; Mebazaa A
    Tunis Med; 2006 Nov; 84(11):724-9. PubMed ID: 17294900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regional variations of low-density lipoprotein oxidizability in hemodialysis patients may explain discrepancies in interventional therapy on oxidative profile.
    Morena M; Gausson V; Mothu N; Bouchet JL; Chanas M; Grandvuillemin M; Robert A; Vela C; Canaud B; Cristol JP; Olmer M
    Blood Purif; 2008; 26(3):300-10. PubMed ID: 18451643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients.
    Noordzij M; Korevaar JC; Bos WJ; Boeschoten EW; Dekker FW; Bossuyt PM; Krediet RT
    Nephrol Dial Transplant; 2006 Sep; 21(9):2513-20. PubMed ID: 16799173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modified lipoproteins and cardiovascular risk.
    Aldahi W; Frohlich J
    Adv Exp Med Biol; 2001; 498():41-8. PubMed ID: 11900400
    [No Abstract]   [Full Text] [Related]  

  • 32. Lysophosphatidylcholine, oxidized low-density lipoprotein and cardiovascular disease in Korean hemodialysis patients: analysis at 5 years of follow-up.
    Lee YK; Lee DH; Kim JK; Park MJ; Yan JJ; Song DK; Vaziri ND; Noh JW
    J Korean Med Sci; 2013 Feb; 28(2):268-73. PubMed ID: 23400766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxidative cross-linking of ApoB100 and hemoglobin results in low density lipoprotein modification in blood. Relevance to atherogenesis caused by hemodialysis.
    Ziouzenkova O; Asatryan L; Akmal M; Tetta C; Wratten ML; Loseto-Wich G; Jürgens G; Heinecke J; Sevanian A
    J Biol Chem; 1999 Jul; 274(27):18916-24. PubMed ID: 10383389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipoprotein oxidation biomarkers for cardiovascular risk: what does the future hold?
    Taleb A; Tsimikas S
    Expert Rev Cardiovasc Ther; 2012 Apr; 10(4):399-402. PubMed ID: 22458571
    [No Abstract]   [Full Text] [Related]  

  • 35. Use of an easy commercially available software (VISICALC) on a low-cost personal computer (APPLE II PLUS) to assess a dialysis simulation model.
    Vancini C
    Life Support Syst; 1983; 1 Suppl 1():126-8. PubMed ID: 6336391
    [No Abstract]   [Full Text] [Related]  

  • 36. Carbamylation of proteins and atherogenesis in renal failure.
    Roxborough HE; Young IS
    Med Hypotheses; 1995 Aug; 45(2):125-8. PubMed ID: 8531833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Free knot splines for biochemical data.
    Molinari N; Morena M; Cristol JP; Daurè JP
    Comput Methods Programs Biomed; 2002 Mar; 67(3):163-7. PubMed ID: 11853941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Kinetic modeling of LDL oxidation using software (NELOP program) and validation in a population at vascular risk].
    Morena M; Vaussenat F; Maggi MF; Canaud B; Cristol JP; Descomps B
    J Soc Biol; 1999; 193(2):211-7. PubMed ID: 10451355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation between oxidized low density lipoproteins and von Willebrand factor in chronic renal failure.
    Holvoet P; Donck J; Landeloos M; Brouwers E; Luijtens K; Arnout J; Lesaffre E; Vanrenterghem Y; Collen D
    Thromb Haemost; 1996 Nov; 76(5):663-9. PubMed ID: 8950769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis.
    Bossola M; Tazza L; Merki E; Giungi S; Luciani G; Miller ER; Lin EB; Tortorelli A; Tsimikas S
    Blood Purif; 2007; 25(5-6):457-65. PubMed ID: 18075247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.